These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4173029)

  • 1. Subcutaneous sarcomas induced by mitomycin C in mice: comparisons of occurrence, transplantability and histology between sarcomas induced by actinomycin S and 3-methylcholanthrene.
    Ikegami R; Akamatsu Y; Haruta M
    Acta Pathol Jpn; 1967 Nov; 17(4):495-501. PubMed ID: 4173029
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosomal changes in 20-methylcholanthrene induced sarcomas in mice in relation to time of appearance of the tumours.
    Hansteen IL; Refsum SB
    Virchows Arch B Cell Pathol; 1969; 4(1):1-7. PubMed ID: 4982322
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell proliferation and time of appearance of sarcomas induced with 20-methylcholanthrene in mice.
    Hansteen IL; Refsum SB
    Virchows Arch B Cell Pathol; 1969; 4(1):8-15. PubMed ID: 4982328
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity.
    Kearney R; Nelson DS
    Aust J Exp Biol Med Sci; 1973 Dec; 51(6):723-35. PubMed ID: 4788454
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of Candida albicans glycoprotein on 3-methylcholanthrene induced malignancy in newborn rodents.
    Mankowski ZT
    Mycopathol Mycol Appl; 1971 May; 44(2):95-100. PubMed ID: 4930335
    [No Abstract]   [Full Text] [Related]  

  • 6. Actinomycin-D-resistant in vitro mouse cell line derived from a methylcholanthrene-induced sarcoma: decrease of malignancy and antigenic characteristics.
    Belehradek J; Biedler JL; Thonier M; Barski G
    Int J Cancer; 1974 Dec; 14(6):779-88. PubMed ID: 4142788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A spontaneously metastasizing 20-methylcholanthrene-induced rhabdomyosarcoma and its transformation to ascites form in the CBA mouse.
    Mellgren J; Bartholdsson E; Boeryd B; Norrby K
    Acta Pathol Microbiol Scand; 1966; 68(4):535-46. PubMed ID: 5958849
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour cell volume changes in vivo induced by heparin.
    Norman M; Norrby K
    Pathol Eur; 1971; 6(3):268-77. PubMed ID: 5114236
    [No Abstract]   [Full Text] [Related]  

  • 9. [On negative results in the cell-free transplantation attempts of chemically-induced sarcomas].
    Hoffmann F; Graffi A
    Arch Geschwulstforsch; 1967; 29(4):315-23. PubMed ID: 4299073
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapeutic effect of allogeneic tumor cells on the growth of autochthonous 3-methylcholanthrene-induced sarcomas in rats.
    Kudo H; Suga M; Ogasawara M; Sato T; Usubuchi I
    Tohoku J Exp Med; 1979 Apr; 127(4):353-8. PubMed ID: 442081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAILURE OF OSTEOLYTIC AGENTS TO INDUCE SKELETAL METASTASES IN RATS WITH SARCOMA.
    GARDNER B; EISENBERG E; SCHMIDT DM
    Cancer; 1965 Sep; 18():1085-8. PubMed ID: 14332536
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific immunoprotection with 3 M KCl solubilized tumor antigen.
    Kahan BD; Pellis NR
    J Surg Res; 1975 Mar; 18(3):263-9. PubMed ID: 1134089
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell clones with different sensitivity to cytostatic drugs in methylcholanthrene-induced mouse sarcomas.
    Håkansson L; Tropé C
    Acta Pathol Microbiol Scand A; 1974 Jan; 82(1):41-7. PubMed ID: 4827350
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence of common antigenic properties in chemically induced sarcomas of mice.
    Reiner J; Southam CM
    Cancer Res; 1967 Jul; 27(7):1243-7. PubMed ID: 4952516
    [No Abstract]   [Full Text] [Related]  

  • 15. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
    Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
    Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the oncogenic response of newborn mice to various chemical carcinogens. II. Induction of subcutaneous sarcoma with 9,10-dimethyl-1,2-benzanthracene and with 20-methylcholanthrene in Swiss mice C57BL and C3Hf/Gs].
    Tridente G; Mazzarella L; Pennelli N; Fiore-Donati L
    Boll Soc Ital Biol Sper; 1964 Jun; 40(11):607-10. PubMed ID: 5876350
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of subcutaneous administration of chemical carcinogens on leukemia in C58 mice.
    Whitmire CE
    J Natl Cancer Inst; 1979 Mar; 62(3):555-9. PubMed ID: 216841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune status of the primary host toward its own methylcholanthrene-induced sarcomas.
    Stjernswärd J
    J Natl Cancer Inst; 1968 Jan; 40(1):13-22. PubMed ID: 5635014
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heterogeneity of murine sarcoma cells for transplantability due to their different susceptibilities to the lytic action of macrophages].
    Ustinov AS; Lavrovskiĭ VA
    Biull Eksp Biol Med; 1988 Mar; 105(3):322-4. PubMed ID: 3349171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic host response to primary methylcholanthrene-induced sarcomas in rats immunized with allogeneic tumors.
    Kudo H; Sato T; Kakisaka Y; Nishimura S; Kano M
    Tohoku J Exp Med; 1975 Nov; 117(3):283-8. PubMed ID: 1202658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.